Contact

Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

Wilhelmus Johannes Wytenburg has worked on the following 68 EPO patent applications which have been published in the last five years:

EP11741505

PROTEIN KINASE C INHIBITORS AND USES THEREOF

IPC classification:
A61K 31/506, A61P 35/00, C07D 401/14
Applicant:
Rigel Pharmaceuticals Inc
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11764056

MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO

IPC classification:
A61K 31/506, A61P 3/00, C07D 413/14
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12709201

CRYSTALLINE FORMS AND PROCESSES FOR THE PREPARATION OF CONDENSED AZACYCLES ( CANNABINOID RECEPTOR MODULATORS)

IPC classification:
A61K 31/416, A61P 29/00, C07D 403/04
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12716763

CANNABINOID RECEPTOR MODULATORS

IPC classification:
A61K 31/416, A61K 31/4439, A61K 31/497, A61K 31/661, A61P 29/00, C07D 231/54, C07D 401/04, C07D 401/14, C07D 403/04, C07D 405/14, C07F 9/09
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12786332

QUINAZOLINE-7-ETHER COMPOUNDS AND METHODS OF USE

IPC classification:
A61K 31/517, A61P 35/00, C07D 405/12, C07D 493/04
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12792550

TRICYCLIC INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE

IPC classification:
A61K 31/395, A61P 9/10, A61P 29/00, A61P 35/00, C07F 9/6584
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP10850372

COMPOSITIONS COMPRISING ENZYME-CLEAVABLE PRODRUGS OF ACTIVE AGENTS AND INHIBITORS THEREOF

IPC classification:
A01N 43/42, A61K 31/44
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11772435

PERIPHERAL OPIOID AGONISTS AND PERIPHERAL OPIOID ANTAGONISTS

IPC classification:
A01N 43/42, A61K 31/44
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11750116

DERIVATIZED HYPERBRANCHED POLYGLYCEROLS

IPC classification:
A61K 9/00, A61K 9/51, A61K 47/10, A61K 47/34, A61K 47/48, C08G 65/22, C08G 65/329, C08G 65/34, C08G 65/48, C08G 83/00
Applicant:
The University of British Columbia
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Agent:
ABG Patentes SL
Status:
EXAMINATION IN PROGRESS
EP12844804

PAK INHIBITORS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS

IPC classification:
A61K 31/519, A61P 35/00, C07D 403/10, C07D 405/14, C07D 471/04
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION REFUSED
EP12845870

PAK INHIBITORS FOR THE TREATMENT OF FRAGILE X SYNDROME

IPC classification:
A61K 31/519, A61P 25/00, C07D 401/10, C07D 471/04
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11772437

COMPOSITIONS COMPRISING ENZYME-CLEAVABLE AMPHETAMINE PRODRUGS AND INHIBITORS THEREOF

IPC classification:
A61K 31/16, A61K 45/06, A61K 47/48, C07C 237/22, C07C 279/14
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12784666

5-(PYRIDIN-2-YL-AMINO)-PYRAZINE-2-CARBONITRILE COMPOUNDS AND THEIR THERAPEUTIC USE

IPC classification:
A61K 31/497, A61P 35/00, C07D 401/12, C07D 401/14
Applicant:
Cancer Research Technology Ltd
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12859248

GUANINE ANALOGS AS TELOMERASE SUBSTRATES AND TELOMERE LENGTH AFFECTORS

IPC classification:
A61K 31/675, A61K 31/683, A61K 31/685, A61K 31/688, A61P 35/00, A61P 35/02, A61P 35/04, C07F 9/6561
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13738359

BENZOHETEROCYCLIC COMPOUNDS AND USE THEREOF

IPC classification:
A61K 31/41, A61K 31/42, A61K 31/425, A61K 31/433, A61P 29/00, A61P 35/00, C07D 209/02, C07D 231/54, C07D 263/54, C07D 277/62, C07D 285/14
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12787319

MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO

IPC classification:
A61K 31/496, A61P 9/00, C07D 241/04
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP14173149

Therapeutic compounds

IPC classification:
A61K 31/05, A61P 25/20, C07C 37/055, C07C 39/06, C07C 271/44
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13704701

MORPHOLINOALKYL FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE

IPC classification:
A61K 31/42, A61P 25/00, A61P 29/00, A61P 37/00, C07D 265/30
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13709994

3-ARYL-5-SUBSTITUTED-ISOQUINOLIN-1-ONE COMPOUNDS AND THEIR THERAPEUTIC USE

IPC classification:
A61K 31/472, A61K 31/4725, A61K 31/496, A61K 31/506, A61P 35/00, C07D 217/14, C07D 217/16, C07D 401/04, C07D 401/10, C07D 401/12, C07D 401/14, C07D 405/12, C07D 487/04, C07D 487/08, C07D 487/10
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13768915

PHENYL-UREA AND PHENYL-CARBAMATE DERIVATIVES AS INHIBITORS OF PROTEIN AGGREGATION

IPC classification:
A61K 31/17, A61K 31/27
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13773141

PROTEIN KINASE C INHIBITORS AND USES THEREOF

IPC classification:
A01N 43/40, A61K 31/445, A61K 31/505, A61K 31/535
Applicant:
Rigel Pharmaceuticals Inc
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13723910

5-[[4-[[MORPHOLIN-2-YL]METHYLAMINO]-5-(TRIFLUOROMETHYL)-2-PYRIDYL]AMINO]PYRAZINE-2-CARBONITRILE AND THERAPEUTIC USES THEREOF

IPC classification:
A61K 31/506, A61P 35/00, C07D 401/12
Applicant:
Cancer Research Technology Ltd
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13729851

TREATMENT OF MULTIPLE SCLEROSIS AND PSORIASIS USING PRODRUGS OF METHYL HYDROGEN FUMARATE

IPC classification:
A61K 31/265, A61K 31/5375, A61P 17/06, A61P 25/00, C07C 235/14, C07D 207/02, C07D 295/104
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14182803

Modulators of the prostacyclin (PG12) receptor useful for the treatment of disorders related thereto

IPC classification:
A61K 31/17, A61K 31/27, A61P 43/00, C07C 271/08, C07C 275/18
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13816903

PREVENTION OF ALCOHOL REACTION WITH DIETARY SUPPLEMENTS

IPC classification:
A23L 1/30, A61K 31/122
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13820320

DI-AND TRI-HETEROARYL DERIVATIVES AS INHIBITORS OF PROTEIN AGGREGATION

IPC classification:
A61K 31/496
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13756971

METHODS OF ADMINISTERING MONOMETHYL FUMARATE AND PRODRUGS THEREOF HAVING REDUCED SIDE EFFECTS

IPC classification:
A61K 9/28, A61K 31/225, A61K 31/5375, A61P 17/06, A61P 25/00, A61P 29/00
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13759076

ORAL DOSAGE FORMS OF METHYL HYDROGEN FUMARATE AND PRODRUGS THEREOF

IPC classification:
A61K 9/16, A61K 9/28, A61K 31/225, A61K 31/5375, A61P 17/06, A61P 25/00, A61P 29/00
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13756261

ORAL DOSAGE FORMS OF METHYL HYDROGEN FUMARATE AND PRODRUGS THEREOF

IPC classification:
A61K 9/16, A61K 9/28, A61K 31/225, A61K 31/5375, A61P 17/06, A61P 25/00, A61P 29/00
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11715123

MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO

IPC classification:
A61K 31/445, A61K 31/454, A61K 31/495, A61P 3/10, C07D 211/46, C07D 401/04, C07D 401/12, C07D 401/14, C07D 405/12, C07D 405/14, C07D 413/04, C07D 413/06, C07D 413/14, C07D 417/14
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11729441

(R)-1,2-PROPANEDIOL FOR USE AS A SOLVENT IN THERAPEUTIC COOLING AGENT COMPOSITIONS

IPC classification:
A61K 31/223, A61K 47/10, A61P 11/00, A61P 17/04
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13805533

COMBINATION THERAPY USING BELINOSTAT AND TRABECTEDIN

IPC classification:
A61K 31/196, A61K 31/4995, A61K 45/06
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP13853588

COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE

IPC classification:
A61K 31/4152, A61K 39/00
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13855289

HYDRAZINYL-INDOLE COMPOUNDS AND CONJUGATES

IPC classification:
C07D 403/00
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13859485

INHIBITOR OF APOPTOSIS PROTEIN (IAP) ANTAGONISTS

IPC classification:
A61K 31/5365, A61P 35/00, C07D 487/04, C07D 498/04
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Agent:
HGF Limited
Status:
GRANT OF PATENT INTENDED
EP13812297

PROTEIN KINASE C INHIBITORS AND USES THEREOF

IPC classification:
C07D 455/02
Applicant:
Rigel Pharmaceuticals Inc
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14701137

BIPHENYL-ETHYL-PYRROLIDINE DERIVATIVES AS HISTAMINE H3 RECEPTOR MODULATORS FOR THE TREATMENT OF COGNITIVE DISORDERS

IPC classification:
A61K 31/40, A61K 31/4025, A61K 31/41, A61P 3/04, A61P 25/04, A61P 25/08, A61P 25/18, A61P 25/24, A61P 25/28, A61P 37/08, C07D 257/04, C07D 295/14
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Agent:
Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB
Status:
EXAMINATION IN PROGRESS
EP15156493

Combination therapy using an HDAC inhibitor and Vincristine for treating cancer

IPC classification:
A61K 31/138, A61K 31/18, A61K 31/196, A61K 31/198, A61K 31/24, A61K 31/337, A61K 31/4745, A61K 31/475, A61K 31/513, A61K 31/517, A61K 31/519, A61K 31/555, A61K 31/573, A61K 31/706, A61K 31/7068, A61K 31/7076, A61K 33/24, A61K 45/06, A61P 35/00
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14729498

PROTEIN KINASE C INHIBITORS AND USES THEREOF

IPC classification:
A61K 31/437, A61P 35/00, C07D 471/04
Applicant:
Rigel Pharmaceuticals Inc
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11758011

SALTS OF LORCASERIN WITH OPTICALLY ACTIVE ACIDS

IPC classification:
A61K 31/55, A61P 3/04, C07D 223/16
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14725519

FLUORO-PERHEXILINE COMPOUNDS AND THEIR THERAPEUTIC USE

IPC classification:
A61K 31/445, A61P 9/04, C07D 211/38
Applicant:
The University Court of The University of Aberdeen
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14733041

CORTICOSTEROID COMPOSITIONS

IPC classification:
A61K 9/06, A61K 31/56, A61K 31/57, A61K 31/573, A61K 31/58, A61K 47/14
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP10850371

COMPOSITIONS COMPRISING ENZYME-CLEAVABLE OPIOID PRODRUGS AND INHIBITORS THEREOF

IPC classification:
A01N 43/42, A61K 31/44
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14735642

N-(4-HYDROXY-4-METHYL-CYCLOHEXYL)-4-PHENYL-BENZENESULFONAMIDES AND N-(4-HYDROXY-4-METHYL-CYCLOHEXYL)-4-(2-PYRIDYL)BENZENESULFONAMIDES AND THEIR THERAPEUTIC USE

IPC classification:
A61K 31/18, A61K 31/4418, A61P 29/00, C07C 311/20, C07D 213/61
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP11754919

POLYETHYLENE GLYCOL COMPOSITIONS FOR CONTROLLING RELAPSE OF HERPES LABIALIS, HERPES GENITALIS, AND HERPES ZOSTER

IPC classification:
A61K 31/765, A61P 31/22
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11755511

FAST-DISSOLVE DOSAGE FORMS OF 5-HT2C AGONISTS

IPC classification:
A61K 31/55, A61P 3/04, C07D 223/16
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14753395

METHODS OF ADMINISTERING MONOMETHYL FUMARATE AND PRODRUGS THEREOF HAVING REDUCED SIDE EFFECTS

IPC classification:
A61K 31/215, A61K 31/225, C12Q 1/48, C12Q 1/68
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP11709770

3,3-DISUBSTITUTED-(8-AZA-BICYCLO[3.2.1]OCT-8-YL)-[5-(1H-PYRAZOL-4-YL)-THIOPHEN-3-YL]-METHANONES AS INHIBITORS OF 11(BETA)-HSD1

IPC classification:
A61K 31/4535, A61K 31/46, A61P 3/04, A61P 3/10, A61P 9/00, A61P 25/00, A61P 25/28, C07D 409/14, C07D 451/02, C07D 451/04, C07D 451/06
Applicant:
The University of Edinburgh
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14772500

CRYSTALLINE FORMS OF (N,N-DIETHYLCARBAMOYL)METHYL METHYL (2E)BUT-2-ENE-1,4-DIOATE, METHODS OF SYNTHESIS AND USE

IPC classification:
A61K 31/225, A61P 3/10, A61P 11/06, A61P 17/06, A61P 25/28, A61P 29/00, A61P 31/12, A61P 31/18, A61P 31/22, C07C 235/06
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14781338

LIQUID PROTEIN FORMULATIONS CONTAINING ORGANOPHOSPHATES

IPC classification:
A61K 9/00, A61K 9/19, A61K 38/00, A61K 39/00, A61K 47/18, A61K 47/20, C07K 1/14
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14781337

LIQUID PROTEIN FORMULATIONS CONTAINING WATER SOLUBLE ORGANIC DYES

IPC classification:
A61K 9/00, A61K 9/08, A61K 9/19, A61K 38/00, A61K 39/00, A61K 39/395, A61K 47/18, A61K 47/20, C07K 1/14
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14766786

3-ARYL-5-SUBSTITUTED-ISOQUINOLIN-1-ONE COMPOUNDS AND THEIR THERAPEUTIC USE

IPC classification:
A61K 31/472, A61K 31/4725, A61P 35/00, C07D 217/24, C07D 401/10, C07D 401/14, C07D 413/10, C07D 413/14, C07D 471/08
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14846876

PHOSPHORODIAMIDATE BACKBONE LINKAGE FOR OLIGONUCLEOTIDES

IPC classification:
A61K 31/7125, A61K 48/00, A61P 35/00, C07H 19/10, C07H 19/20, C07H 21/04, C12N 15/113
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13783630

DI-ISOPROPYL-PHOSPHINOYL-ALKANE (DAPA) COMPOUNDS AS TOPICAL AGENTS FOR THE TREATMENT OF SENSORY DISCOMFORT

IPC classification:
A61K 31/662, A61P 17/00, A61P 25/24, C07F 9/53
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14860025

POLYNUCLEOTIDE CONSTRUCTS HAVING DISULFIDE GROUPS

IPC classification:
C07F 9/02, C12P 19/34
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP11715726

[((1R,2S,5R)-2-ISOPROPYL-5-METHYL-CYCLOHEXANECARBONYL)-AMINO]-ACETIC ACID ISOPROPYL ESTER AND RELATED COMPOUNDS AND THEIR USE IN THERAPY

IPC classification:
A61K 31/223, A61P 11/00, A61P 27/02, C07C 233/63
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP14866158

HYDRAZINYL-PYRROLO COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE

IPC classification:
A61K 31/4045
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14806358

1 -(5-TERT-BUTYL-2-ARYL-PYRAZOL-3-YL)-3-[2-FLUORO-4-[(3-OXO-4H-PYRIDO[2, 3-B]PYRAZIN-8-YL)OXY]PHENYL]UREA DERIVATIVES AS RAF INHIBITORS FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/4985, A61P 35/00, C07D 471/04
Applicant:
Cancer Research Technology Ltd
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP11707330

PROCESSES FOR THE PREPARATION OF S1P1 RECEPTOR MODULATORS AND CRYSTALLINE FORMS THEREOF

IPC classification:
A61K 31/407, A61P 31/12, A61P 37/00, C07D 487/04
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15705417

HETEROARYL AMIDES AS INHIBITORS OF PROTEIN AGGREGATION

IPC classification:
A61K 31/4045, A61P 25/28, C07D 417/14
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15706282

PYRAZOLO[1,5-A]PYRIMIDINE-5,7-DIAMINE COMPOUNDS AS CDK INHIBITORS AND THEIR THERAPEUTIC USE

IPC classification:
A61K 31/519, A61P 35/00, C07D 487/04
Applicant:
Emory University
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15776318

METABOTROPIC GLUTAMATE RECEPTOR POSITIVE ALLOSTERIC MODULATORS (PAMS) AND USES THEREOF

IPC classification:
A61K 31/19, A61K 31/41, A61K 31/4245, A61P 25/00, C07C 65/05, C07C 65/10, C07D 257/04, C07D 271/06
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15803360

ANTI-HER2 ANTIBODY-MAYTANSINE CONJUGATES AND METHODS OF USE THEREOF

IPC classification:
A61K 31/4045, A61K 47/50
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15806027

METABOTROPIC GLUTAMATE RECEPTOR NEGATIVE ALLOSTERIC MODULATORS (NAMS) AND USES THEREOF

IPC classification:
A61K 31/4196, A61K 31/426, A61K 31/427, A61K 31/433, C07D 217/06, C07D 249/08, C07D 277/20, C07D 285/08, C07D 417/04
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15812491

CONJUGATES DERIVED FROM NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND METHODS OF USE THEREOF IN IMAGING

IPC classification:
A61K 47/50
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15819578

QUINUCLIDINE COMPOUNDS FOR MODULATING ALPHA7 -NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVITY

IPC classification:
A61K 31/439, A61P 25/28, C07D 209/04, C07D 453/02, C07D 471/08
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15759570

FUMARATE ANALOGS AND USES THEREOF IN THE TREATMENT OF AN AUTOIMMUNE DISEASE OR AN INFLAMMATORY DISEASE

IPC classification:
A61K 31/41, A61P 17/06, A61P 37/00, C07D 257/04, C07D 401/04, C07D 403/12, C07D 405/04, C07D 405/06
Applicant:
Rigel Pharmaceuticals Inc
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15836833

NOVEL ULK1 INHIBITORS AND METHODS USING SAME

IPC classification:
A61K 31/505, A61K 31/506, A61K 31/517, A61K 31/519, A61P 27/00, A61P 35/00
Applicant:
Yale University
Agent:
Wilhelmus Johannes Wytenburg, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature